Skip to content

Effect of the supplement on accommodation of eye in middle- and old-aged adults : A randomized, double blinded, placebo controlled, and parallel group comparison study.

Effect of the supplement on accommodation of eye in middle- and old-aged adults : A randomized, double blinded, placebo controlled, and parallel group comparison study. - Effect of supplement on accommodation of eye.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035790
Enrollment
40
Registered
2019-02-07
Start date
2019-02-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

New Drug Research Center Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. From 35 to 64 years old 2. Binocular vision is more than 1.0 at naked or corrected eyesight . The specifications of eye-contact lens or glasses cannot be changed and replaced with new ones during the test period. 3. Have no eye diseases other than refractive error (near-sightedness, far-sightedness and astigmatism) 4. Near point distance is lower than the age average. 5. The person who can go to facilities on check days 6.Written informed consent

Exclusion criteria

Exclusion criteria: 1. Risk of onset of pollen allergy during the study period (February to April) 2. Conduct of lasik surgery during the past 6 months 3. Presence or history of hepatitis diseases or severe renal, endocrine, cardiovascular, gastric, lung, hematologic and metabolic disorder diseases 4. Current medications (excluding on-demand use) 5. Can't stop to take a supplement during the study period. 6. Presence or history of drug/food allergy 7. Receipt of investigational product in other clinical studies during the past one month or currently participating in other clinical studies 8. Female who is pregnant, breast-feeding or intends to become pregnant 9. Patients whom principal investigator judges inappropriate to invite to this study

Design outcomes

Primary

MeasureTime frame
Accommodation of eye (4 weeks after ingestion)

Countries

Japan

Contacts

Public ContactShimpei Tomita

New drug research center, Inc. R&D Center, Research Dept., Clinical Research Dept.

s-tomita@ndrcenter.co.jp0123-34-0412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026